Potential New Therapeutic Pathway For Parkinson’s Disease Identified

Study traces disease progression from the gut to the brain via immune cells, highlighting opportunities for earlier intervention.

Header Image

Fresh scientific evidence sheds new light on how Parkinson’s disease may develop and spread in the body. By pinpointing the role of immune cells in transporting toxic proteins from the gut to the brain, the research opens up a possible therapeutic strategy that could be applied well before motor symptoms emerge.

Parkinson’s disease and the gut–brain connection

Scientists have long suspected that Parkinson’s disease may originate in the gut. This theory is based on the fact that one of the first brain regions affected is the dorsal motor nucleus of the vagus nerve, which is directly connected to the digestive system. What remained unclear, however, was how the disease process travels from the gut to the brain.

The role ensuring of gut immune cells

A new mouse study conducted by researchers at the UK Dementia Research Institute at University College London identifies a central role for gut macrophages. These specialised immune cells normally act as a first line of defence, engulfing and destroying harmful invaders. The study shows that they can also transport toxic proteins linked to Parkinson’s disease from the gut towards the brain.

Key findings from the study

The research, published in the scientific journal Nature and funded by the Chan Zuckerberg Initiative, demonstrated that reducing the number of gut macrophages in mice limited the spread of the toxic protein. This was accompanied by an improvement in motor symptoms.

Implications for early treatment

These findings point to a new potential therapeutic approach for Parkinson’s disease. By targeting the immune processes involved in the early stages of disease spread, it may be possible to intervene before the onset of the hallmark motor symptoms.

Next steps in research

The research team plans to further examine how the immune system can negatively affect the brain and whether this mechanism can be used to develop new drug targets. At the same time, they will explore the use of inflammation markers in the blood as potential tools for the early diagnosis of Parkinson’s disease.

Source: CNA

Comments Posting Policy

The owners of the website www.politis.com.cy reserve the right to remove reader comments that are defamatory and/or offensive, or comments that could be interpreted as inciting hate/racism or that violate any other legislation. The authors of these comments are personally responsible for their publication. If a reader/commenter whose comment is removed believes that they have evidence proving the accuracy of its content, they can send it to the website address for review. We encourage our readers to report/flag comments that they believe violate the above rules. Comments that contain URLs/links to any site are not published automatically.